We are exploring a new treatment using modified T cells for patients with certain blood cancers who have received a transplant from specific donors. The study aims to see if this approach is safe and effective.
Health conditions and diseases that the clinical trial is designed to study and treat.
This condition involves patients with blood cancers (hematological malignancies) who are HLA-DPB1*04:01 positive and have received a transplant from a genetically matched donor or cord blood that is HLA-DPB1*04:01 negative.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.